Researchers used AI models to design antibodies that neutralize over 1,300 SARS-CoV-2 strains, including Delta and Omicron.

Research from the University of Virginia School of Medicine has revealed crucial new insights into the immune systems of ...

Center at UCSF is pioneering the development of potent drug candidates aimed at preventing future coronavirus pandemics.